Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ITCI market cap is 9.08B. The company's latest EPS is USD -1.3175 and P/E is -65.01.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 126.17M | 132.1M | 144.87M | 161.39M | 175.38M |
| Operating Income | -29.71M | -34.1M | -20.95M | -27.72M | -38.85M |
| Net Income | -24.26M | -28.58M | -15.25M | -16.22M | -26.32M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 61k | 22.81M | 83.8M | 250.31M | 464.37M |
| Operating Income | -154.01M | -231.23M | -285.69M | -263.63M | -159.38M |
| Net Income | -147.72M | -227.01M | -284.13M | -256.26M | -139.67M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 717.66M | 728.3M | 747.04M | 1.32B | 1.32B |
| Total Liabilities | 116.98M | 136.87M | 147.54M | 175.89M | 179.62M |
| Total Equity | 600.68M | 591.42M | 599.5M | 1.14B | 1.14B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 251.19M | 717.31M | 489.92M | 754.78M | 728.3M |
| Total Liabilities | 56.18M | 60.45M | 72.03M | 98.71M | 136.87M |
| Total Equity | 195.01M | 656.86M | 417.89M | 656.07M | 591.42M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -122.14M | -124.2M | -34.12M | -33.57M | -60.1M |
| Investing | 58.12M | 105.54M | 16.18M | 23.95M | -185.26M |
| Financing | 14.81M | 17.81M | 9.99M | 555.17M | 561.9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -127.98M | -230.07M | -259.54M | -270.19M | -124.2M |
| Investing | 177.44M | -480.3M | 280.34M | -128.37M | 105.54M |
| Financing | 3.24M | 664.18M | 11.52M | 455.16M | 17.81M |
| Market Cap | 9.08B |
| Price to Earnings Ratio | -65.01 |
| Price to Sales Ratio | 19.55 |
| Price to Cash Ratio | 61.45 |
| Price to Book Ratio | 15.35 |
| Dividend Yield | - |
| Shares Outstanding | 106.02M |
| Average Volume (1 week) | 390.53k |
| Average Volume (1 Month) | 605.77k |
| 52 Week Change | 43.20% |
| 52 Week High | 93.45 |
| 52 Week Low | 58.78 |
| Spread (Intraday) | 11.94 (13.27%) |
| Company Name | Intra Cellular Therapies Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.intracellulartherapies.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
